CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $39,368
- in 1 filing
Net +$960,625. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 3 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-02-03 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,400 | $13.87 | $33K | 353,778 |
| 2017-02-02 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,400 | $13.45 | $32K | 356,178 |
| 2017-01-18 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,400 | $14.47 | $35K | 358,578 |
| 2017-01-17 | Ciechanover Isaac E. Chief Executive Officer | Sale | −3,600 | $14.08 | $51K | 360,978 |
| 2017-01-17 | Haqq Christopher EVP, R&D & Chief Scientific Of | Sale | −6,000 | $14.27 | $86K | 364,105 |
| 2017-01-06 | Ciechanover Isaac E. Chief Executive Officer | Sale | −6,000 | $17.10 | $103K | 364,578 |
| 2017-01-05 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,400 | $16.36 | $39K | 370,578 |
| 2017-01-03 | SEIDENBERG BETH C Director | Grant or award | +2,000 | 8,689 | ||
| 2017-01-03 | SEIDENBERG BETH C Director | Grant or award · NonQualified Stock Option (Right to Buy) | +5,500 | 5,500 | ||
| 2017-01-03 | HEIDEN WILLIAM K Director | Grant or award | +2,000 | 2,000 | ||
| 2017-01-03 | HEIDEN WILLIAM K Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +5,500 | 5,500 | ||
| 2017-01-03 | MARCUS JOEL S Director | Grant or award | +2,000 | 2,000 | ||
| 2017-01-03 | MARCUS JOEL S Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +5,500 | 5,500 | ||
| 2017-01-03 | Gallagher Carol Giltner Director | Grant or award | +2,000 | 101,010 | ||
| 2017-01-03 | Gallagher Carol Giltner Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +5,500 | 5,500 | ||
| 2017-01-03 | Fust Matthew K Director | Grant or award | +2,000 | 19,093 | ||
| 2017-01-03 | Fust Matthew K Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +5,500 | 5,500 | ||
| 2017-01-03 | DOBMEIER ERIC Director | Grant or award | +2,000 | 7,500 | ||
| 2017-01-03 | DOBMEIER ERIC Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +5,500 | 5,500 | ||
| 2016-12-23 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,400 | $15.25 | $37K | 372,978 |
Page 48 of 71 · 1,403 trades